Evidence map›Paper›PMID 28249070›Full record

ArticleJAMA psychiatry2017

Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability.

Brett Froeliger, Patrick A McConnell, Spencer Bell, Maggie Sweitzer, Rachel V Kozink, Christie Eichberg, Matt Hallyburton, Nicole Kaiser, Kevin M Gray, F Joseph McClernon

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in JAMA psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03960138 (Examining the Effects of Theta Burst Stimulation on Corticothalamic Mediated Inhibitory Control and Smoking Relapse Vulnerability), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03960138 nacompletednot on this mapstarted 2019, after this paper: background citation

Examining the Effects of Theta Burst Stimulation on Corticothalamic Mediated Inhibitory Control and Smoking Relapse Vulnerability

TypeinterventionalSponsorUniversity of Missouri-ColumbiaRan2019 to 2021Enrolled63ConditionsTobacco Use DisorderArmsIntermittent Theta-burst stimulation (iTBS), Continuous Theta-burst stimulation (cTBS)
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Associations Between the Wisconsin Inventory of Smoking Dependence Motives and Regional Brain Volumes in Adult Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Translational Research in Nicotine Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  18. Endogenous theta stimulation during meditation predicts reduced opioid dosing following treatment with Mindfulness-Oriented Recovery Enhancement.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Brett FroeligerDepartment of Neuroscience, Medical University of South Carolina, Charleston2Department of Psychiatry, Medical University of South Carolina, Charleston3Hollings Cancer Center, Medical University of South Carolina, Charleston4Center for Biomedical Imaging, Medical University of South Carolina, Charleston.
Patrick A McConnellDepartment of Neuroscience, Medical University of South Carolina, Charleston.
Spencer BellDepartment of Neuroscience, Medical University of South Carolina, Charleston.
Maggie SweitzerDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Rachel V KozinkDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Christie EichbergDepartment of Neuroscience, Medical University of South Carolina, Charleston.
Matt HallyburtonDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Nicole KaiserDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Kevin M GrayDepartment of Psychiatry, Medical University of South Carolina, Charleston.
F Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina6Brain Imaging and Analysis Center, Duke University Medical Center, Durham, North Carolina.
Medical University of South Carolina · USDuke Medical Center · USDuke University Hospital · USMUSC Hollings Cancer Center · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
DRUG ABUSE TRAINING PROGRAMT32DA007288 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Christopher W Cowan, Rachel Penrod-Martin · 1991 to 2026
$11.8M
Translational Neuropsychopharmacology Research of Nicotine AddictionR01DA038700 · NIDA · UNIVERSITY OF MISSOURI-COLUMBIA · PI FROELIGER, BRETT · 2015 to 2019
$2.9M
Neuroimaging of Nicotine Dependence, Depression and Emotion RegulationR01DA033459 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FROELIGER, BRETT · 2012 to 2016
$1.9M
Brain Substrates of Extinction-Based Treatment for Nicotine DependenceR01DA025876 · NIDA · DUKE UNIVERSITY · PI MCCLERNON, FRANCIS JOSEPH · 2008 to 2012
$1.8M
Targeting reward dysfunction as a mechanism to improve smoking cessationK23DA039294 · NIDA · DUKE UNIVERSITY · PI SWEITZER, MAGGIE M · 2016 to 2020
$817k
NCI NIH HHS P30 CA138313NIDA NIH HHS K23 DA039294NIDA NIH HHS R01 DA025876NIDA NIH HHS R01 DA033459NIDA NIH HHS R01 DA038700NIDA NIH HHS T32 DA007288
6 · The paper itself

Abstract

Importance: Tobacco use disorder is associated with dysregulated neurocognitive function in the right inferior frontal gyrus (IFG)-one node in a corticothalamic inhibitory control (IC) network. Objective: To examine associations between IC neural circuitry structure and function and lapse/relapse vulnerability in 2 independent studies of adult smokers. Design, Setting, and Participants: In study 1, treatment-seeking smokers (n = 81) completed an IC task during functional magnetic resonance imaging (fMRI) before making a quit attempt and then were followed up for 10 weeks after their quit date. In study 2, a separate group of smokers (n = 26) performed the same IC task during fMRI, followed by completing a laboratory-based smoking relapse analog task. Study 1 was performed at Duke University Medical Center between 2008 and 2012; study 2 was conducted at the Medical University of South Carolina between 2013 and 2016. Main Outcomes and Measures: Associations between corticothalamic-mediated IC, gray-matter volume, and smoking lapse/relapse. Results: Of the 81 study participants in study 1 (cessation study), 45 were women (56%), with mean (SD) age, 38.4 (10.2) years. In study 1, smoking relapse was associated with less gray-matter volume (F1,74 = 28.32; familywise error P threshold = 0.03), greater IC task-related blood oxygenation level-dependent (BOLD) response in the right IFG (F1,78 = 14.87) and thalamus (F1,78 = 14.97) (P < .05), and weaker corticothalamic task-based functional connectivity (tbFC) (F1,77 = 5.87; P = .02). Of the 26 participants in study 2 (laboratory study), 15 were women (58%), with mean (SD) age, 34.9 (10.3). Similar to study 1, in study 2, greater IC-BOLD response in the right IFG (t23 = -2.49; β = -0.47; P = .02), and weaker corticothalamic tbFC (t22 = 5.62; β = 0.79; P < .001) were associated with smoking sooner during the smoking relapse-analog task. In both studies, corticothalamic tbFC mediated the association between IC performance and smoking outcomes. Conclusions and Relevance: In these 2 studies, baseline differences in corticothalamic circuitry function were associated with mediated IC and smoking relapse vulnerability. These findings warrant further examination of interventions for augmenting corticothalamic neurotransmission and enhancing IC during the course of tobacco use disorder treatment.

Indexed as

Imaging, Three-DimensionalMagnetic Resonance ImagingAdultCerebral CortexFemaleHumansMaleMiddle AgedNerve NetNeural InhibitionPrefrontal CortexRecurrenceRisk FactorsSmokingSmoking CessationStatistics as Topic

Identifiers

PMID28249070
PMCPMC5562280
OpenAlexW2592248062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.